The widespread increase in drug resistance among bacteria has led to the development of alternative methods to antibiotics to combat microorganisms. In the last decade, bacteriophages have become an important alternative to antibiotics to fight and prevent bacterial infections in people and animals (16). Their high antibacterial efficacy and lack of effect on commensal bacteria, confirmed in numerous experimental phage therapies, provide the basis for further development of their use to treat infections, particularly those caused by multidrug-resistant bacteria (24, 30). One problem potentially limiting the use of bacteriophages in therapy is the possibility of induction of a humoral immune response against phage proteins in the host. As reported by Batinovic
Some reports (6, 8, 11) also confirm the occurrence of natural phage antibodies, which can be produced in humans and animals as a result of the common occurrence of bacteriophages in the environment. For example, bacteriophages have been detected in wastewater, water bodies, soil, food and animal feed, and the oral cavity (dental plaque and saliva) and gastrointestinal tracts of humans and animals, as well as in commercial sera or human vaccines. The total number of bacteriophages in the environment has been estimated at 1032, which is ten times the number of the characterised bacteria (25). Dąbrowska
Administration of bacteriophages can cause an increase in antibodies against phage proteins. Nevertheless, in some studies in humans (18, 32) and in our own previous research in calves (1), despite a humoral response induced by the application of bacteriophage preparations, a therapeutic effect was observed. The outcomes were a significant reduction or even elimination of bacteria and an improved health status. Moreover, it has been suggested that the presence of anti-phage antibodies does not necessarily lead to complete inactivation of phages but allows them to multiply in bacterial cells and cause their lysis (11). The strength of the humoral response against phage proteins and of their consequent inactivation may be influenced by both the type of preparation used (monophage or a cocktail) and the route of administration,
Another significant adverse effect of phage therapy is the possibility of an anaphylactic response to foreign phage proteins. However, this type of reaction has been shown to be infrequent; bacteriophages may induce an increase in the expression of the anti-inflammatory interleukin (IL)-1 receptor antagonist (IL-1RA) and stimulate IL-10, an anti-inflammatory cytokine that blocks the expression of pro-inflammatory cytokines such as IL-1 and IL-6 and inhibits the activity of Th1 cells, NK cells and macrophages (10).
The predominant health problems in calves in feedlot and dairy production are respiratory and gastrointestinal diseases, both of which affect animal welfare and economic outcomes in cattle production, causing losses because of mortality and treatment and future production costs. Estimates of the prevalence of bovine respiratory disease induced by
The aims of the study were to assess the extent of any induction of a specific anti-phage humoral immune response by selected bacteriophage components of experimental phage preparations used in calves and to assess the preservation of their antibacterial properties. This was prompted by the significant health problems in cattle caused by
The control sera were obtained from calves that had not previously been treated with bacteriophages (1, 31), as well as from healthy calves which had not previously had contact with the bacteriophages used in the experimental treatments. All tested sera were coming from the collection owned by the Department of Veterinary Prevention and Avian Diseases of the University of Life Sciences in Lublin. Foetal bovine serum (FBS, Sigma-Aldrich, St. Louis, MO, USA) was additionally used as a negative control.
For coating of plates with selected phage proteins, the electrophoresis-derived proteins were eluted using the ReadyPrep Protein Extraction Kit (Total Protein – Bio-Rad) according to the manufacturer’s instructions. Then the proteins were separated in 2D electrophoresis and characterised by matrix-assisted laser desorption/ ionisation–time of flight mass spectrometry (MALDI-TOF) (29). Selected proteins of the phages specific for
Antigen in the form of 100 μL of purified phage preparations was used to coat the 96-well flat-bottom microplates, which were incubated overnight at 4°C. The same procedure was used to coat the plates with phage proteins. Then they were washed five times with 350 μL of phosphate-buffered saline (PBS) with Tween 20 (Tween 20 = 0.1%), and 200 μL of blocking protein (1% solution of casein sodium salt from bovine milk in PBS; Sigma-Aldrich) was applied to the microplate wells to block any non-specific binding sites. The plates were incubated for two hours with 3% skim milk at room temperature, after which phages were added for binding. The microplates were then incubated again for 1 h at 37°C. Bovine serum samples were used as primary antibodies and were diluted in blocking solution with the addition of 0.05% Tween 20 in proportions of 1:1000 and 1:10,000. Each serum sample was applied in duplicate by pipetting 100 μL of the solution to each well. The microplates were loaded with 100 μL/well of secondary antibody solution and incubated again for 1 h at 37 °C. Specific anti-phage antibodies bound to antigen were detected by goat horseradish peroxidase (HRP)–conjugated secondary antibodies specific for bovine IgG, IgA or IgM (Sigma-Aldrich). All anti-bovine secondary antibodies were diluted in blocking solution with 0.05% Tween 20 in a proportion of 1 : 5000. After 3 h incubation at room temperature, 200 μL of o-phenylenediamine (Sigma-Aldrich) suspended in 0.05 M phosphate-citrate buffer containing 0.03% sodium perborate (Sigma-Aldrich) was added to each well, and the plates were incubated at room temperature for a minimum of 15 min in the dark. Then the microplates were shaken and immediately read on a multiwell plate reader (BioRad) at 450 nm. Foetal bovine serum was used as a negative control (Sigma-Aldrich).
The phage inactivation rate was estimated using the following formula proposed by Żaczek
K = 2.3 × (D/T) × log(P0/Pt)
where:
K – phage inactivation rate,
D –reciprocal of serum dilution,
T – time of onset of reaction in minutes (in this case after 30 min),
P0 – phage titre at the start of reaction,
Pt – phage titre after reaction.
In accordance with the cited study we assumed that K < 5 indicated weak neutralisation of phages, K ≥ 5–K ≤ 18 indicated moderate neutralisation, and K > 18 indicated a high level of phage neutralisation.
Next, the mixture was diluted 100-fold with enriched broth, and the phage titre was determined by the double-layer plate method according to Huff
Two main phage proteins were obtained with molecular weights of approximately 92.5 and 69 kDa (Fig. 1), shown by the electrophoretic separations in the SDS-PAGE electropherograms.
Sodium dodecyl sulphate–polyacrylamide gel electrophoresis electropherograms with phage proteins
A: Lines 1, 2 and 3 – 25 A2 and A5 phages specific for
M –10–240 kDa molecular weight protein ladder
Analysis of the electropherograms of phage proteins isolated in 2D electrophoresis revealed two main proteins in a pH range of 4.5–5.9. The height of the two most notable spots, evaluated in MALDI TOF analysis, ranged from 39.008 to 78.966 kDa (Fig. 2).
Two-dimensional electrophoresis of phage proteins
A – phages specific for
M – 7–240 kDa molecular weight standard
Average absorbance values (±standard deviation) measured in serum samples from calves by ELISA in response to application of bacteriophages specific for
Parameter | FBS | Calves with clinical signs of disease after phage application | Healthy calves after phage application | Healthy calves not treated with phages | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
IgG | IgM | IgA | IgG | IgM | IgA | IgG | IgM | IgA | IgG | IgM | IgA | |
Mean level of antibodies against whole |
0.007 ± 0.004 | 0.008 ± 0.006 | 0.001 ± 0.0009 | 0.64 ± 0.09ab | 0.192 ± 0.068ab | 0.114 ± 0.048ab | 0.845 ± 0.111ab | 0.239 ± 0.082ab | 0.021 ± 0.007a | 0.056 ± 0.024a | 0.019 ± 0.00a | 0.017 ± 0.01a |
Mean level of antibodies against whole |
0.0032 ± 0.001 | 0.014 ± 0.008 | 0.001 ± 0.0008 | 0.74 ± 0.16ab | 0.211 ± 0.052ab | 0.19 ± 0.09ab | 0.71 ± 0.13ab | 0.203 ± 0.2ab | 0.029 ± 0.003a | 0.06 ± 0.009a | 0.096 ± 0.038a | 0.02 ± 0.007a |
Mean level of antibodies against whole |
0.005 ± 0.004 | 0.004 ± 0.0001 | 0.002 ± 0.0005 | 0.95 ± 0.08ab | 0.99 ± 0.111ab | 0.23 ± 0.005ab | 0.6 ± 0.1a | 0.33 ± 0.02ab | 0.02 ± 0.002a | 0.72 ± 0.017a | 0.08 ± 0.03a | 0.03 ± 0.001a |
Mean level of antibodies against |
0.005 ± 0.003 | 0.009 ± 0.007 | 0.001 ± 0.0005 | 0.71 ± 0.134ab | 0.18 ± 0.34ab | 0.15 ± 0.05ab | 0.53 ± 0.13ab | 0.226 ± 0.13ab | 0.03 ± 0.016 | 0.06 ± 0.01a | 0.07 ± 0.04a | 0.02 ± 0.0009a |
Mean level of antibodies against |
0.004 ± 0.003 | 0.002 ± 0.0009 | 0.001 ± 0.0001 | 0.83 ± 0.032ab | 0.21 ± 0.004ab | 0.201 ± 0.002ab | 0.68 ± 0.15ab | 0.21 ± 0.004ab | 0.099 ± 0.007a | 0.062 ± 0.001a | 0.042 ± 0.002a | 0.02 ± 0.008a |
Mean level of antibodies against |
0.007 ± 0.004 | 0.004 ± 0.002 | 0.001 ± 0.000 | 0.77 ± 0.13ab | 0.3 ± 0.04ab | 0.15 ± 0.03ab | 0.65 ± 0.21ab | 0.26 ± 0.18 ab | 0.05 ± 0.02a | 0.071 ± 0.04a | 0.05 ± 0.02a | 0.03 ± 0.01a |
FBS – foetal bovine serum; Ig – immunoglobulin; a – significant differences (P ≤ 0.05) in comparison to control (FBS); b – significant differences (P ≤ 0.05) in comparison to sera from calves not treated with phages
The highest concentrations of anti-phage antibodies were observed for IgG in the sera of calves that had received phages specific for
Average values obtained in the phage neutralisation assay
Type of phage solution | Mean K ± SD in untreated calves | Mean K ± SD in treated calves |
---|---|---|
0.0019 ± 0.001 | 7.28 ± 0.54* | |
0.0046 ± 0.003 | 5.57 ± 1.81* | |
0.00156 ± 0.0004 | 6.74 ± 0.5* | |
0.0013 ± 0.0005 | 5.053 ± 1.53* |
K – phage inactivation rate; SD – standard deviation; * – Wilcoxon’s test P ≤ 0.05
The results of the study confirm that bacteriophages can induce the production of anti-phage antibodies (mainly IgG and IgM) in calves, which can contribute to inactivation of phages. A statistically significant (P ≤ 0.05) increase in the antibody level relative to the control (foetal bovine serum) was observed in all tested sera obtained from calves that had received bacteriophages and those that had no contact with the phages contained in the experimental phage preparations. The results are similar to those obtained by Żaczek
The differences in absorbance observed in the present study for different immunoglobulin classes indicate that the phages had varied effects on immune response mechanisms in the calves. The lack of significant differences in IgA levels between the sera may indicate that the immunomodulatory effect of the phages was small or that the immune response was diffused among the large pool of antigens involved in immunomodulation. In a study by Majewska
The present study also showed no statistically significant differences (P ≤ 0.05) in absorbance depending on the route of administration, whether intranasal (
Irrespective of the route of administration of bacteriophages in various animal species,
It also seems interesting that the present study showed the presence of IgG and IgM phage antibodies in the sera of healthy calves that had had no physical contact with the bacteriophage preparations, as they were from other farms. These results may indicate the presence of physiological and possibly commensal, bacteriophages as part of the natural microbiome of the gastrointestinal and respiratory tracts, in part a consequence of the natural occurrence of saprophytic
The presence of these bacteria and bacteriophages specific for them in the body may be a physiological factor that naturally induces the production of anti-phage antibodies. The occurrence of “natural” phages within the body has been confirmed by researchers such as Nguyen
The present study showed that bacteriophages had a significant effect on the neutralising potential of calf serum in comparison to this potential of the serum of calves that were not treated with phages. However, no statistically significant differences were found between the immunogenic effects of whole phages and phage proteins. This suggests that phage preparations containing purified phage antigens will not stimulate a stronger immune response, as is also the case with vaccines containing purified antigen fragments of microbes, which additionally require an adjuvant to strengthen the immune response.
The relationship between phage administration and the induction of an anti-phage immune response is currently the subject of numerous studies, which have been presented in a review article by Hodyra-Stefaniak
The results of the present study also indicate that the induction of an anti-phage response by phages did not significantly affect their antibacterial efficacy. Other measurable effects confirming that the lytic activity of phages was preserved, as shown in our previous research (1, 28), were an improvement in health status and a protective effect lasting for at least three weeks after the final administration of the phages, as well as a significant reduction in the concentration of pathogenic
The results of the present study as well as those presented by other authors indicate that bacteriophages can induce a humoral immune response in humans and animals. However, there are differences in the strength of the response induced and the potential effectiveness of phage treatments in fighting infections. Despite differences in the levels of induction of anti-phage antibodies, the effects of phage therapies are promising, as they reduce clinical symptoms or even bring full recovery. Because of the lack of comprehensive knowledge of the kinetics and immunomodulatory potential of bacteriophages, their use to eliminate pathogenic bacteria is still a developing field and research must be continued in order to provide a full understanding of their role in human and animal health.